首页> 美国卫生研究院文献>Acta Crystallographica Section F: Structural Biology and Crystallization Communications >Characterization crystallization and preliminary X-ray crystallographic analysis of the human Uba5 C-terminus–Ufc1 complex
【2h】

Characterization crystallization and preliminary X-ray crystallographic analysis of the human Uba5 C-terminus–Ufc1 complex

机译:Uba5 C末端–Ufc1复合物的表征结晶和初步X射线晶体学分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Human Uba5, which contains an adenylation domain and a C-terminal region, is the smallest ubiquitin-like molecule-activating enzyme. The mechanism through which the enzyme recognizes Ufc1 and catalyzes the formation of the Ufc1–Ufm1 complex remains unknown. In this study, Uba5 residues 364–404 were demonstrated to be necessary for the transthiolation of Ufm1 to Ufc1, and Uba5 381–404 was identified to be the minimal region for Ufc1 recognition. The fusion protein between Uba5 381–404 and Ufc1 was cloned, expressed and purified, and exists as a homodimer in solution. Crystallization was performed at 293 K using PEG 4000 as precipitant; the optimized crystals diffracted to 3.0 Å resolution and had unit-cell parameters a = b = 82.49, c = 62.47 Å, α = β = 90, γ = 120°. With one fusion-protein molecule in the asymmetric unit, the Matthews coefficient and solvent content were calculated to be 2.55 Å3 Da−1 and 51.84%, respectively.
机译:包含腺苷酸化域和C端区域的人Uba5是最小的泛素样分子激活酶。该酶识别Ufc1并催化Ufc1-Ufm1复合物形成的机制尚不清楚。在这项研究中,Uba5残基364–404被证明对于Ufm1到Ufc1的硫代转移是必需的,并且Uba5 381–404被识别为Ufc1识别的最小区域。 Uba5 381–404和Ufc1之间的融合蛋白被克隆,表达和纯化,并以同型二聚体形式存在于溶液中。使用PEG 4000作为沉淀剂,在293 K下进行结晶。优化后的晶体衍射至3.0Å的分辨率,其晶胞参数a = b = 82.49,c = 62.47Å,α=β= 90,γ= 120°。以一个不对称单元中的融合蛋白分子计算,马修斯系数和溶剂含量分别为2.55Å 3 Da -1 和51.84%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号